Literature DB >> 8788068

Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the Rhesus monkey.

Y Tani1, T Ishihara, T Kanai, T Ohno, J Andersson, A Lilja, G Antoni, K J Fasth, P Bjurling, G Westerberg.   

Abstract

The effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP) on the central cholinergic and dopaminergic systems in the Rhesus monkey brain were investigated by positron emission tomography (PET) with the muscarinic cholinergic receptor ligands (N-[11C]methyl-benztropine) and dopaminergic receptor ligands selective for D1, D2, and D3 subtypes ([11C]SCH23390, N-[11C]methyl-spiperone, and (+)[11C]UH232, respectively). None of the doses (3, 10, and 30 mg/kg i.v.) of R-THBP used significantly affected the regional cerebral blood flow (rCBF as determined by Raichle's H(2)15O method), and 10 mg/kg of R-THBP had little effect on the regional cerebral metabolic rate of glucose (rCMRglc) in the Rhesus monkey brain, as assessed by the graphical [18F]fluoro-deoxyglucose method. The effect of R-THBP on the muscarinic cholinergic system was dose dependent; while 3 mg/kg of R-THBP did not significantly alter the uptake ratio of N-[11C]methylbenztropine in several brain regions to that in the cerebellum, 10 and 30 mg/kg of R-THBP significantly reduced the uptake ratio in the thalamus, as well as in the frontal and temporal cortices. None of the doses (3, 10, and 30 mg/kg i.v.) of R-THBP tested affected [11C]SCH23390 (dopamine D1 receptor) binding. However, the k3 value for N-[11C]methyl-spiperone (dopamine D2 receptor) binding, which represents the association rate X Bmax value, was significantly decreased in the striatum. The uptake ratio of (+)[11C]UH232 (dopamine D3 receptor) in the striatum to that in the cerebellum was also decreased by administration of R-THBP (3 and 30 mg/kg i.v.). These findings suggest that R-THBP acts on dopamine D2 and D3 receptors selectively without markedly affecting dopamine D1 receptor binding. Furthermore, the changes in cholinergic and dopamine D2 and D3 receptors in vivo can not be attributed to a change in rCBF but may depend on the action of R-THBP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788068     DOI: 10.1007/bf01281154

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  46 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine.

Authors:  S L Dewey; R R MacGregor; J D Brodie; B Bendriem; P T King; N D Volkow; D J Schlyer; J S Fowler; A P Wolf; S J Gatley
Journal:  Synapse       Date:  1990       Impact factor: 2.562

3.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Authors:  P Sokoloff; B Giros; M P Martres; M L Bouthenet; J C Schwartz
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

4.  Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures.

Authors:  K Wienhard; G Pawlik; K Herholz; R Wagner; W D Heiss
Journal:  J Cereb Blood Flow Metab       Date:  1985-03       Impact factor: 6.200

5.  6R-tetrahydrobiopterin perfusion enhances dopamine, serotonin, and glutamate outputs in dialysate from rat striatum and frontal cortex.

Authors:  N Mataga; K Imamura; Y Watanabe
Journal:  Brain Res       Date:  1991-06-14       Impact factor: 3.252

6.  SCH 23390 - the first selective dopamine D-1 antagonist.

Authors:  J Hyttel
Journal:  Eur J Pharmacol       Date:  1983-07-15       Impact factor: 4.432

7.  Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.

Authors:  C Morar; S B Whitburn; J A Blair; R J Leeming; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

8.  Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay.

Authors:  T Nagatsu; T Yamaguchi; T Kato; T Sugimoto; S Matsuura; M Akino; I Nagatsu; R Iizuka; H Narabayashi
Journal:  Clin Chim Acta       Date:  1981-02-05       Impact factor: 3.786

9.  Enhancement of acetylcholine release in the hippocampus by 6R-L-erythro-5,6,7,8-tetrahydrobiopterin is mediated by 5-hydroxytryptamine.

Authors:  T Ohue; K Koshimura; Y Takagi; Y Watanabe; S Miwa; T Masaki
Journal:  Brain Res       Date:  1993-04-02       Impact factor: 3.252

10.  Tetrahydrobiopterin administration to rhesus macaques. Its appearance in CSF and effect on neurotransmitter synthesis.

Authors:  L Miller; T Insel; M Scheinin; J Aloi; D L Murphy; M Linnoila; W Lovenberg
Journal:  Neurochem Res       Date:  1986-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.